
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
AmMax is a private biotechnology company focused on the clinical development of innovative cancer therapeutics. The Company strategically acquires oncology assets to develop into innovative and clinically meaningful products. The company identifies new mechanisms for new indications and pursues first-in-class or best-in-class therapeutics with manageable development risk. The company is focused on leveraging its CSF1R mAb platform licensed from Amgen, to launch multiple oncology products that address colorectal cancer with minimal residual disease (CRC MRD), tenosynovial giant cell tumors (TGCT), and an antibody-drug-conjugate construction for acute myeloid leukemia (AML). AmMax has a very experienced management team, led by Dr. Larry...
Oncology,tgct,molecular residual disease,minimal residual disease,colorectal cancer,and aml
Ammax bio., inc operates in the Pharmaceutical manufacturing industry.
Ammax bio., inc's revenue is 11m - 100m
Ammax bio., inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.